Lastra C F, Mariño E L, Barrueco M, Gervós M S, Gil A D
Antimicrob Agents Chemother. 1984 Apr;25(4):458-62. doi: 10.1128/AAC.25.4.458.
The pharmacokinetics of phosphomycin were studied in seven patients with pleural effusion of varied etiologies. All patients received a single intravenous bolus of 30 mg of antibiotic per kg. Phosphomycin levels in plasma and pleural fluid were determined simultaneously. Antibiotic levels in plasma followed a two-compartment open kinetic model. In the pleural fluid, maximum concentrations of phosphomycin, 42.63 +/- 16.03 micrograms/ml (mean +/- standard deviation), were reached at 3.69 +/- 1.08 h after administration of the antibiotic. The disappearance constant of the antibiotic from the pleural fluid was significantly smaller (0.16 +/- 0.06 h-1) than the elimination constant determined from the levels of drug in plasma (0.73 +/- 0.26 h-1). Phosphomycin persisted in antibacterial concentrations in the pleural fluid for a considerable period of time. The low accessibility of phosphomycin observed in one of the patients in the study, with a maximum concentration value of 2.16 micrograms of phosphomycin per ml of pleural fluid, could be due to the existence of pachypleuritis in that patient; this was later confirmed in clinical and histological studies done after the research described here.
在7例病因各异的胸腔积液患者中研究了磷霉素的药代动力学。所有患者均接受了每千克体重30毫克抗生素的单次静脉推注。同时测定血浆和胸腔积液中的磷霉素水平。血浆中的抗生素水平遵循二室开放动力学模型。在胸腔积液中,给药后3.69±1.08小时达到磷霉素的最大浓度,为42.63±16.03微克/毫升(平均值±标准差)。抗生素从胸腔积液中的消失常数(0.16±0.06小时-1)明显小于根据血浆中药物水平确定的消除常数(0.73±0.26小时-1)。磷霉素在胸腔积液中以抗菌浓度持续相当长一段时间。在该研究的一名患者中观察到磷霉素的可达性较低,胸腔积液中磷霉素的最大浓度值为每毫升2.16微克,这可能是由于该患者存在胸膜肥厚;这在本文所述研究之后进行的临床和组织学研究中得到了证实。